Rare mutations in XRCC2 increase the risk of breast cancer

American Journal of Human Genetics

Volumn 90, Issue 4, 2012, Pages 734-739

  Park, D J ^a   Lesueur, F ^b   Nguyen Dumont, T ^a   Pertesi, M ^b   Odefrey, F ^a   Hammet, F ^a   Neuhausen, S L ^c   John, E M ^d,e   Andrulis, I L ^f   Terry, M B ^g   Daly, M ^h   Buys, S ⁱ   Le Calvez Kelm, F ^b   Lonie, A ^j   Pope, B J ^j   Tsimiklis, H ^a   Voegele, C ^b   Hilbers, F M ^k   Hoogerbrugge, N ^l   Barroso, A ^m   Osorio, A ^m,n   Giles, G G ^o   Devilee, P ^k   Benitez, J ^m,n   Hopper, J L ^a   Tavtigian, S V ⁱ   Goldgar, D E ^p   Southey, M C ^a   more..

^a UNIVERSITY OF MELBOURNE   (Australia)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^d CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

^e STANFORD CANCER INSTITUTE   (United States)

^f MOUNT SINAI HOSPITAL   (Canada)

^g Columbia University ^*  (United States)

^h FOX CHASE CANCER CENTER   (United States)

ⁱ UNIVERSITY OF UTAH   (United States)

^j Victorian Life Sciences Computation Initiative   (Australia)

^k LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^l RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^m Centro Nacional de Investigaciones Oncológicas   (Spain)

ⁿ Spanish Network on Rare Diseases ^*  (Spain)

^o CANCER EPIDEMIOLOGY CENTRE   (Australia)

^p UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; NUCLEAR PROTEIN; PROTEIN XRCC2; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER SCREENING; CASE CONTROL STUDY; DNA REPAIR; ENZYME INHIBITION; EXOME; FAMILY STUDY; FANCONI ANEMIA; GENE MUTATION; GENE SEQUENCE; GENE TARGETING; GENETIC CODE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HOMOLOGOUS RECOMBINATION; HUMAN; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; POPULATION RESEARCH; PRIORITY JOURNAL;

ADULT; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; EXOME; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HOMOLOGOUS RECOMBINATION; HUMANS; MALE; MIDDLE AGED; MUTATION; PEDIGREE; RISK;

EID: 84859479737     PISSN: 00029297     EISSN: 15376605     Source Type: Journal    
DOI: 10.1016/j.ajhg.2012.02.027     Document Type: Article

References (25)

1. C. Turnbull, and N. Rahman Genetic predisposition to breast cancer: Past, present, and future Annu. Rev. Genomics Hum. Genet. 9 2008 321 345
2. E.M. John, J.L. Hopper, J.C. Beck, J.A. Knight, S.L. Neuhausen, R.T. Senie, A. Ziogas, I.L. Andrulis, H. Anton-Culver, N. Boyd Breast Cancer Family Registry The Breast Cancer Family Registry: An infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer Breast Cancer Res. 6 2004 R375 R389
3. Giles, G.G., and R, E.D. (2002). The Melbourne Collaborative Cohort Study. IARC Sci Publ 156, 2.
4. R. Cartwright, C.E. Tambini, P.J. Simpson, and J. Thacker The XRCC2 DNA repair gene from human and mouse encodes a novel member of the recA/RAD51 family Nucleic Acids Res. 26 1998 3084 3089
5. B. Deans, C.S. Griffin, P. O'Regan, M. Jasin, and J. Thacker Homologous recombination deficiency leads to profound genetic instability in cells derived from Xrcc2-knockout mice Cancer Res. 63 2003 8181 8187
6. C.E. Tambini, K.G. Spink, C.J. Ross, M.A. Hill, and J. Thacker The importance of XRCC2 in RAD51-related DNA damage repair DNA Repair (Amst.) 9 2010 517 525
7. M.E. Moynahan, J.W. Chiu, B.H. Koller, and M. Jasin Brca1 controls homology-directed DNA repair Mol. Cell 4 1999 511 518
8. M.E. Moynahan, A.J. Pierce, and M. Jasin BRCA2 is required for homology-directed repair of chromosomal breaks Mol. Cell 7 2001 263 272
9. A. Meindl, H. Hellebrand, C. Wiek, V. Erven, B. Wappenschmidt, D. Niederacher, M. Freund, P. Lichtner, L. Hartmann, and H. Schaal Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene Nat. Genet. 42 2010 410 414
10. H.E. Shamseldin, M. Elfaki, and F.S. Alkuraya Exome sequencing reveals a novel Fanconi group defined by XRCC2 mutation J. Med. Genet. 49 2012 184 186
11. L.-B. Gao, X.-M. Pan, L.-J. Li, W.-B. Liang, Y. Zhu, L.-S. Zhang, Y.-G. Wei, M. Tang, and L. Zhang RAD51 135G/C polymorphism and breast cancer risk: A meta-analysis from 21 studies Breast Cancer Res. Treat. 125 2011 827 835
12. C. Loveday, C. Turnbull, E. Ramsay, D. Hughes, E. Ruark, J.R. Frankum, G. Bowden, B. Kalmyrzaev, M. Warren-Perry, K. Snape Breast Cancer Susceptibility Collaboration (UK) Germline mutations in RAD51D confer susceptibility to ovarian cancer Nat. Genet. 43 2011 879 882
13. N. Liu, D. Schild, M.P. Thelen, and L.H. Thompson Involvement of Rad51C in two distinct protein complexes of Rad51 paralogs in human cells Nucleic Acids Res. 30 2002 1009 1015
14. C.S. Griffin, P.J. Simpson, C.R. Wilson, and J. Thacker Mammalian recombination-repair genes XRCC2 and XRCC3 promote correct chromosome segregation Nat. Cell Biol. 2 2000 757 761
15. W.-Y. Lin, N.J. Camp, L.A. Cannon-Albright, K. Allen-Brady, S. Balasubramanian, M.W.R. Reed, J.L. Hopper, C. Apicella, G.G. Giles, and M.C. Southey A role for XRCC2 gene polymorphisms in breast cancer risk and survival J. Med. Genet. 48 2011 477 484
16. S. Rafii, P. O'Regan, G. Xinarianos, I. Azmy, T. Stephenson, M. Reed, M. Meuth, J. Thacker, and A. Cox A potential role for the XRCC2 R188H polymorphic site in DNA-damage repair and breast cancer Hum. Mol. Genet. 11 2002 1433 1438
17. F. Le Calvez-Kelm, F. Lesueur, F. Damiola, M. Vallée, C. Voegele, D. Babikyan, G. Durand, N. Forey, S. McKay-Chopin, N. Robinot Breast Cancer Family Registry Rare, evolutionarily unlikely missense substitutions in CHEK2 contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening study Breast Cancer Res. 13 2011 R6
18. S.V. Tavtigian, P.J. Oefner, D. Babikyan, A. Hartmann, S. Healey, F. Le Calvez-Kelm, F. Lesueur, G.B. Byrnes, S.-C. Chuang, N. Forey Australian Cancer Study Breast Cancer Family Registries (BCFR) Kathleen Cuningham Foundation Consortium for Research into Familial Aspects of Breast Cancer (kConFab) Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer Am. J. Hum. Genet. 85 2009 427 446
19. G.J. Mann, H. Thorne, R.L. Balleine, P.N. Butow, C.L. Clarke, E. Edkins, G.M. Evans, S. Fereday, E. Haan, M. Gattas Kathleen Cuningham Consortium for Research in Familial Breast Cancer Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource Breast Cancer Res. 8 2006 R12
20. Y.C. Ding, L. Steele, L.-H. Chu, K. Kelley, H. Davis, E.M. John, G.E. Tomlinson, and S.L. Neuhausen Germline mutations in PALB2 in African-American breast cancer cases Breast Cancer Res. Treat. 126 2011 227 230
21. D.E. Goldgar, S. Healey, J.G. Dowty, L. Da Silva, X. Chen, A.B. Spurdle, M.B. Terry, M.J. Daly, S.M. Buys, M.C. Southey BCFR kConFab Rare variants in the ATM gene and risk of breast cancer Breast Cancer Res. 13 2011 R73
22. M. Tischkowitz, M. Capanu, N. Sabbaghian, L. Li, X. Liang, M.P. Vallée, S.V. Tavtigian, P. Concannon, W.D. Foulkes, L. Bernstein The WECARE Study Collaborative Group Rare germline mutations in PALB2 and breast cancer risk: A population-based study Hum Mutat 33 2012 674 680
23. N. Rahman, S. Seal, D. Thompson, P. Kelly, A. Renwick, A. Elliott, S. Reid, K. Spanova, R. Barfoot, T. Chagtai Breast Cancer Susceptibility Collaboration (UK) PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene Nat. Genet. 39 2007 165 167
24. S. Seal, D. Thompson, A. Renwick, A. Elliott, P. Kelly, R. Barfoot, T. Chagtai, H. Jayatilake, M. Ahmed, K. Spanova Breast Cancer Susceptibility Collaboration (UK) Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles Nat. Genet. 38 2006 1239 1241
25. C. Turnbull, S. Seal, A. Renwick, M. Warren-Perry, D. Hughes, A. Elliott, D. Pernet, S. Peock, J.W. Adlard, J. Barwell Breast Cancer Susceptibility Collaboration (UK), EMBRACE Gene-gene interactions in breast cancer susceptibility Hum. Mol. Genet. 21 2012 958 962